NL-OMON35439已完成3 期
Effect of Olmesartan Medoxomil on arterial stiffness and thickness in subjects with metabolic syndrome. - Effect OM arterial stiffness, thickness with metabolic syndrome
Daiichi Sankyo Europe0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >= 18 and <= 75 years
- •- Hypertension and metabolic syndrome defined, according to the ATP III/ IDF 2005 and ESH/ESC 2007 definitions with modifications;
- •see Amended Protocol Version NL-1.0 page 25
排除标准
- •- Pregnant or lactating female;
- •- Type 1 and type 2 diabetes;
- •- *High range* mild hypertension;
- •- Moderate, severe, or resistant hypertension;
- •- Secondary hypertension of any aetiology;
- •- Kidney function impairment;
- •see protocol page 25 + see Substantial Amendment 1, page 6 of 9 + Substantial Amendment the Netherlands-specific 1, page 5 of 7 + Amended Protocol Version NL-1.0 page 26
研究者
相似试验
进行中（未招募）
1 期
Effect of olmesartan medoxomil on arterial stiffness and thickness in subjects with metabolic syndrome - NDHypertension, metabolic syndromeMedDRA version: 9.1Level: SOCClassification code 10007541Term: Cardiac disordersMedDRA version: 9.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersEUCTR2007-003131-23-ITSANKYO EUROPE350
进行中（未招募）
1 期
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-BEDAIICHI SANKYO EUROPE GmbH264
进行中（未招募）
不适用
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-NLDAIICHI SANKYO EUROPE GmbH350
进行中（未招募）
1 期
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1 Level: LLT Classification code 10052066 Term: Metabolic syndromeMedDRA version: 9.1 Level: LLT Classification code 10020772 Term: HypertensionEUCTR2007-003131-23-GBDAIICHI SANKYO EUROPE GmbH350
进行中（未招募）
不适用
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-DEDAIICHI SANKYO EUROPE GmbH264